• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Resident Writer's Award Winner

Article

Editor's Note: Omesh P. Gupta, MD, MBA, a senior ophthalmology resident and co-chief resident at Wills Eye at Jefferson, Philadelphia, was named the winner of the fourth annual Ophthalmology Times Resident Writer's Award Program-presented at the 2006 American Academy of Ophthalmology meeting in Las Vegas.

Editor's Note: Omesh P. Gupta, MD, MBA, a senior ophthalmology resident and co-chief resident at Wills Eye at Jefferson, Philadelphia, was named the winner of the fourth annual Ophthalmology Times Resident Writer's Award Program-presented at the 2006 American Academy of Ophthalmology meeting in Las Vegas.

Dr. Gupta was nominated by William Tasman, MD, ophthalmologist-in-chief at Wills Eye and professor of ophthalmology at Thomas Jefferson University, Philadelphia, and Tara Uhler, director of resident education and assistant professor of ophthalmology. His winning submission is featured here. The case was presented in conjunction with Robert S. Bailey Jr., MD, director of the Department of Cataract and Primary Eye Care and attending surgeon at Wills Eye.

Dr. Gupta graduated magna cum laude from the University of Rochester in 1998 with a Bachelor of Science degree in molecular genetics and minors in architecture and biomedical engineering. He was then the first graduate of the combined 5-year MD/ MBA program at the University of Rochester School of Medicine and Dentistry and William E. Simon Graduate School of Business Administration.

In 1839, Wills Eye established the first ophthalmology residency program in the United States. Advancements in phacoemulsification, IOL development, and vitrectomy were pioneered by Wills Eye staff and former residents. For 16 consecutive years, Wills Eye has ranked as one of the top three ophthalmology centers by the U.S. World & News Report. Dr. Gupta is one of 25 residents at Wills Eye, one of the largest ophthalmic programs in the country. Residents rotate through 11 services, including the Wills Eye Emergency Room. The emergency room is open 24 hours a day, 7 days a week, with thousands of patient visits per year.

Related Videos
Paul Badawi, co-founder and CEO of Sight Sciences, chats with Neda Shamie, MD, about what drives him
© 2024 MJH Life Sciences

All rights reserved.